OMNICELL, INC. (NASDAQ:OMCL) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
its financial results for the quarter ended March 31, 2017. The
full text of the press release issued in connection with the
announcement is attached as Exhibit 99.1 to this Current Report
on Form 8-K and is incorporated herein by reference.
shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act,
except as expressly set forth by specific reference in such a
filing.
|
Number
|
Description of Document
|
|
|
99.1
|
Press release entitled “Omnicell Announces First
Quarter 2017 Results” dated May 4, 2017 |
About OMNICELL, INC. (NASDAQ:OMCL)
Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products. OMNICELL, INC. (NASDAQ:OMCL) Recent Trading Information
OMNICELL, INC. (NASDAQ:OMCL) closed its last trading session up +0.55 at 42.05 with 290,983 shares trading hands.
